Complete response with fluorouracil and irinotecan with a BRAF(V600E) and EGFR inhibitor in BRAF-mutated metastatic colorectal cancer: a case report

BACKGROUND: Patients with BRAF (v-Raf murine sarcoma viral oncogene homolog B) V600E-mutated metastatic colorectal cancer (mCRC) have a poor prognosis. The Southwest Oncology Group (SWOG) 1406 study evaluated the efficacy of vemurafenib in combination with irinotecan and cetuximab for simultaneous i...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhan, Dai, Wei-Ping, Zang, Yuan-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329477/
https://www.ncbi.nlm.nih.gov/pubmed/30662270
http://dx.doi.org/10.2147/OTT.S180845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329477/
https://www.ncbi.nlm.nih.gov/pubmed/30662270
http://dx.doi.org/10.2147/OTT.S180845

Ejemplares similares